Microsynergy Pharmaceuticals launched operations in 2014 as a Middle Eastern pharmaceutical company; a joint venture between Synergy Pharma and Micro Labs India Limited. Headquartered in Dubai Science Park, UAE.
Microsynergy Pharmaceuticals is poised to provide high quality affordable lifesaving drugs. Our products are manufactured under stringent quality checks at manufacturing facilities following the cGMP , approved by USFDA and UAE authorities. We were instrumental in introducing the first generics of Celecoxib, Ebastine and Serratiopeptidase to UAE.
MICROSYNERGY PHARMACEUTICALS strives to be way ahead of other pharmaceutical manufacturers in the region with its distinct portfolio developed, internally or through acquisitions and licensing. Particular focus will be on Skeleto- Muscular diseases, Gynecology, Cardio metabolic disorders and Pediatrics.
In-house developments and extraneous R&D in different parts of the world will be finally converged into MICROSYNERGY Portfolio, offering the best in class treatment options to the patients..